In this investigation, we studied the ability of human cytomegalovirus to infect peripheral blood mononuclear cells. With monoclonal antibody technology, we demonstrated that cytomegalovirus could infect human lymphocytes of T-and B-cell (PBM). Infectious CMV has occasionally been found in buffy-coat preparations (4-6) obtained from patients with clinical CMV infection; only rarely has the virus been isolated from healthy donors (7). Neither the exact cell involved in the leukocyte fraction nor the state of the virus in such cells has been established. When transformed lymphoblastoid and erythroleukemia cell lines were studied for the ability to support CMV replication, some researchers found evidence of short-term virus replication (8, 9), but rarely was infectious virus produced (10, 11). There have been occasional reports of expression of CMV antigens on B-lymphoblastoid cell lines (12). Attempts to infect normal PBM from healthy donors with laboratory-adapted strains of CMV have failed (11, 13).
Human cytomegalovirus (CMV) infection is frequently associated with severe immunosuppression, especially in the clinical settings of allograft transplantation (1) and the acquired immunodeficiency syndrome (2) . Where the virus is harbored, how the viral genome is expressed, and whether the immunosuppression is mediated directly by the virus or indirectly by another mechanism are important, but as yet unanswered, questions. Former studies with murine CMV in our laboratory suggested that this virus is harbored in a latent state in a subset of B-lymphocytes (3). However, until now, workers in several laboratories failed to demonstrate similar CMV infection of human peripheral blood mononuclear cells (PBM) . Infectious CMV has occasionally been found in buffy-coat preparations (4) (5) (6) obtained from patients with clinical CMV infection; only rarely has the virus been isolated from healthy donors (7) . Neither the exact cell involved in the leukocyte fraction nor the state of the virus in such cells has been established. When transformed lymphoblastoid and erythroleukemia cell lines were studied for the ability to support CMV replication, some researchers found evidence of short-term virus replication (8, 9) , but rarely was infectious virus produced (10, 11) . There have been occasional reports of expression of CMV antigens on B-lymphoblastoid cell lines (12) . Attempts to infect normal PBM from healthy donors with laboratory-adapted strains of CMV have failed (11, 13) .
In the cascade regulation of the CMV genome (14) , immediate-early protein synthesis precedes early polypeptide synthesis, both of which set the regulatory state for late polypeptide synthesis and production of mature virions. The early class polypeptides appear to have predominantly regulatory functions; the late polypeptides have mainly structural functions. We reasoned that if lymphocytes were abortively infected, techniques such as cocultivation assays and probes for late CMV gene products would be negative. Hence, we looked for CMV expression in peripheral blood lymphocytes (PBL) with monoclonal antibodies specifically produced to detect polypeptides relevant to major epochs in the cascade regulation of the viral genome. Prompted by observations of biological differences between strains of virus recently derived from infected patients and the fibroblastadapted strains of virus (15) , we also studied both forms of this virus.
MATERIALS AND METHODS
Lymphocyte Infection. PBM were removed from the blood of healthy human donors by density gradient centrifugation on Ficoll-Paque and infected at a multiplicity of 0.01-1.0 with CMV recently isolated from patients with various CMV syndromes (Table 1) , or with stocks of plaque-purified laboratory-strain AD-169. The recent isolates were propagated in human foreskin fibroblasts (Flow Laboratories) for <12 passages. Because low-passage isolates of human virus are associated predominantly with the cell matrix (15), infected or mock-infected fibroblasts were sonicated, and this material was cultured with PBM for up to 6 days. Thereafter, the PBM were washed 3 times and prepared for immunofluorescence studies by air-drying and fixing the cells with acetone on glass slides. In some experiments, T-lymphocytes were positively selected from the PBM cultures by erythrocyterosetting techniques (17) or by sorting on a fluorescence-activated cell sorter (16) .
Immunofluorescence Techniques. Monoclonal antibodies were raised against CMV-infected fibroblasts with standard techniques (18) . CMV polypeptide specificities were determined by immunofluorescence and standard radioimmunoprecipitation techniques and polyacrylamide gel electrophoresis (19) , as outlined in Table 2 . After these monoclonal antibodies were allowed to react with the cells, bound antibody was determined by indirect immunofluorescence with fluorescein-labeled pepsin-digested goat antibody to mouse immunoglobulin and by fluorescence microscopy. As 
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The appearance of peripheral blood T-cells infected with a recent isolate of CMV and probed for CMV antigen expression with the monoclonal antibody L14, is shown in Fig. 1 . T-lymphocytes in this example were purified from cultures of infected PBM by two sheep erythrocyte-rosetting procedures and were >99% pure. When probed with the monoclonal antibody L-14, specific to the major 72-kDa immediateearly protein, 15% of the cells exhibited nuclear or perinuclear fluorescence. The same result was obtained with another monoclonal antibody reagent also specific to the major immediate-early gene product (19) but not with monoclonal antibody reagents specific to late gene products. The same phenomenon was demonstrated in T-lymphocytes that had been selected from the cultures by cell-sorter technology. Hence, the infection in PBM and in purified T-lymphocytes appeared to be abortive. In corroboration, we could not detect mature virions in these cells by electron microscopy, nor was infectious virus demonstrable by infectious center assays (data not shown). Einhorn and Ost have recently described a similar restricted infection of human mononuclear cells by CMV (20) .
Restricted infection with human CMV has been described in some mouse (21) and rabbit (22) cell lines. Virus transcription in these two models may be blocked in a manner common to both. DeMarchi has provided evidence that productive and nonproductive infection may differ at the level at which some early transcripts associate with polysomes (23). We are currently investigating this possibility in lymphocytes infected with CMV.
CMV infection of PBL was most easily demonstrable with the low-passage human isolates. In only 1 of 10 experiments were we able to show immediate-early antigen expression in Table 3 (which was representative of three), 3.2% of the total mononuclear cell population expressed a polypeptide detectable by L-14. Similar results were obtained with E-3 (16). As before, late antigens were not detectable in these mononuclear cells. As shown in Table 3, small percentages of T-lymphocytes of helper and suppressor phenotype, B-lymphocytes, and NK cells could be infected by CMV. These data should be interpreted in light of the functional heterogeneity in subsets of mononuclear cells phenotyped by monoclonal antibodies (25) (26) (27) (28) . Among PBM, monocytes comprised the cell population with the tThe techniques used are described in ref. 16. tMonoclonal antibody L-14 detects the major 72-kDa immediateearly protein, with similar reactivity as E-3, obtained from Goldstein et al. (19) . JFunctional and phenotypic heterogeneity among subsets of mononuclear cells (25, 26) likely explains why the total cell number is >100%O. Table 4 (sections 1 and 2) are data from one experiment that compared the immunosuppressive properties of two isolate strains of virus compared to AD-169 and mock-infection. Similarly, the specific proliferative response of immunocompetent cells to herpes simplex virus antigen was aborted by infection of these cells with recent isolate strains of CMV. AD-169 partially suppressed these responses, but even 100-fold greater amounts of AD-169 were significantly less suppressive than the low passage human isolate strains. The suppression of these functions was dependent on the input multiplicity and could be demonstrated with either cell-free or cell-associated virus (unpublished observations).
Similar results were obtained in >20 experiments that examined the effect of 12 isolate strains of CMV on the ability of PBM to act as NK cells. Shown in Table 4 (section 3) are data for three isolates compared to AD-169 and mock-infec- (29) .
It remains uncertain why such significant immunosuppression occurs in vitro when only a small percentage of the mononuclear cells are infected. Both low-passage isolates and the laboratory-adapted strains induce equivalent amounts of interferon from mononuclear cells, making this an unlikely possibility. Since the immunosuppression can be demonstrated with both cell-free and cell-associated virus, it is unlikely that adherence of leukocytes to infected fibroblasts would have significantly decreased cell recovery and, hence, mononuclear cell performance. A more likely explanation is that the suppression of at least some of these functions is mediated through an intermediate cell type. We showed that the monocyte was the mononuclear cell with the greatest propensity for infection by CMV (Table 3 ) and we have preliminary data from monocyte depletion and reconstitution experiments that show that this cell is integral for the demonstration of CMV-mediated immunosuppression.*
Our results indicate that cells of the immune system, including lymphocytes, can be infected by CMV. This conclusion is based on the demonstration of CMV gene products in immunocompetent cells by using specific monoclonal antibodies and immunofluorescent techniques. This infection is abortive, but the differentiated or specialized functions of immune cells can be perturbed without disturbing their vital, or housekeeping, functions. Furthermore, we have described a restriction in CMV replication, at least after the expression of immediate-early genes. Finally, our results suggest a possible mechanism whereby CMV can be introduced into humans by the transfer of blood products, as has been suggested in some experimental models (30, 31 
